Residual contamination in antineoplastic drug packaging.
Luciana Stein E SilvaCibele da Silva Barbosa MachadoRafael LindenMarina Venzon AntunesLaura Cé da SilvaCarlos Alberto Yasin WayhsEdison CappSandro Luís Ribeiro NessPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
The results revealed the presence of residual contamination in the vials and packages of CP and DOX drugs. Although the residues found in each sample are small, special care should be taken in the handling and disposal of the antineoplastic drugs. The use of personal protective equipment is fundamental while handling the vials and packaging of cytotoxic drugs.